ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMDespesas comerciais, gerais e administrativas1.98 B2.2 B2.07 B2.03 B1.8 B8.1 BPesquisa e desenvolvimento——————Lucro operacional1.59 B1.04 B1.41 B1.62 B2.15 B6.21 BLucro não operacional, total-31 M64 M62 M74 M36 M236 MDespesa com juros, líquida de juros capitalizados45 M49 M74 M63 M61 M247 MReceitas não operacionais, líquidas das despesas com juros240 M15 M-12 M11 M246 M260 MReceitas/despesas incomuns-271 M———-271 M—Lucro antes dos impostos1.51 B1.05 B1.4 B1.63 B2.13 B6.2 BParticipação no lucro52 M———52 M—Impostos209 M220 M232 M380 M270 M1.1 BParticipação de minoritários46 M47 M53 M64 M173 M337 MOutras receitas/despesas após impostos-213 M-57 M-112 M-40 M-93 M-302 MLucro líquido antes das operações descontinuadas1.26 B784 M1.11 B1.19 B1.68 B4.76 BOperações descontinuadas0—————Lucro líquido1.26 B784 M1.11 B1.19 B1.68 B4.76 BAjuste de diluição——————Dividendos de ações preferenciais——————Lucro líquido diluído disponível aos acionistas1.26 B784 M1.11 B1.19 B1.68 B4.76 BLucro básico por ação9.966.288.959.6313.6938.55Lucro diluído por ação9.96.258.929.5913.6238.38Número médio de ações básicas127.4 M124.9 M124 M123.2 M123.6 M—Ações diluídas128.1 M125.5 M124.4 M123.7 M124.1 M—EBITDA1.74 B1.19 B1.59 B1.81 B2.35 B6.94 BEBIT1.59 B1.04 B1.41 B1.62 B2.15 B6.21 BCusto da receita87.18 B94.55 B99.61 B102.47 B92.25 B388.88 BOutros componentes do custo——————Amortização e depreciação (fluxo de caixa)151 M157 M188 M188 M196 M729 M
McKesson Corporation Common Stock
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.